Zobrazeno 1 - 2
of 2
pro vyhledávání: '"van Tinteren, Harm"'
Autor:
van den Heuvel-Eibrink, Marry M., Hol, Janna A., Pritchard-Jones, Kathy, van Tinteren, Harm, Furtwangler, Rhoikos, Verschuur, Arnauld C., Vujanic, Gordan M., Leuschner, Ivo, Brok, Jesper, Rube, Christian, Smets, Anne M., Janssens, Geert O., Godzinski, Jan, Ramirez-Villar, Gema L., de Camargo, Beatriz, Segers, Heidi, Collini, Paola, Gessler, Manfred, Bergeron, Christophe, Spreafico, Filippo, Graf, Norbert, Int Soc Paediat Oncology Renal Tu
The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP-RTSG) has developed a new protocol for the diagnosis and treatment of childhood renal tumours, the UMBRELLA SIOP-RTSG 2016 (the UMBRELLA protocol), to continue int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb42baa2fec9e9b5f509ffee316d61d
https://hdl.handle.net/10668/18902
https://hdl.handle.net/10668/18902
Autor:
Lam, Siu W., Nota, Nienke M., Jager, Agnes, Bos, Monique M E M, Van Den Bosch, Joan, Van Der Velden, Ankie M T, Portielje, Johanneke E A, Honkoop, Aafke H., Van Tinteren, Harm, Boven, Epie, De Groot, S. M., Linn, S. C., Braun, H. J., Los, M., Kroep, J. R., Tanis, B., Smorenburg, C. H., Terwogt, J. M Meerum, Van Riel, J. M G H, Den Boer, M. O., Douma, J., Jeurissen, F., Berends, J.
Publikováno v:
Lam, S W, Nota, N M, Jager, A, Bos, M M E M, van den Bosch, J, van der Velden, A M T, Portielje, J E A, Honkoop, A H, van Tinteren, H & Boven, E 2016, ' Angiogenesis-and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy ', Clinical Cancer Research, vol. 22, no. 7, pp. 1611-1620 . https://doi.org/10.1158/1078-0432.CCR-15-1005
Clinical Cancer Research, 22(7), 1611-1620. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(7), 1611. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(7), 1611-1620. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(7), 1611. American Association for Cancer Research Inc.
Purpose: We examined whether pretreatment levels of angiogenesis- or hypoxia-related proteins and their changes after one cycle of first-line bevacizumab-based therapy were associated with response, PFS, or OS in patients with metastatic breast cance